FIELD: medicine.
SUBSTANCE: what is presented is a non-invasive diagnostic technique for foetal aneuploidy by using genomic library.
EFFECT: using enables providing higher sensitivity and selectivity of detecting foetal aneuploidy.
23 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NON-INVASIVE PRENATAL DIAGNOSIS OF FOETAL ANEUPLOIDY | 2014 |
|
RU2583830C2 |
| DIAGNOSTIC TECHNIQUE FOR ANEUPLOIDY BY SEQUENCE ANALYSIS | 2012 |
|
RU2529784C2 |
| METHOD FOR NONINVASIVE PRENATAL DIAGNOSTICS OF FETAL ANEUPLOIDY | 2015 |
|
RU2627673C2 |
| METHOD FOR IDENTIFYING FETAL ANEUPLOIDY IN A BLOOD SAMPLE OF THE PREGNANT WOMAN | 2021 |
|
RU2777072C1 |
| METHOD FOR NON-INVASIVE PRENATAL SCREENING OF FETAL ANEUPLOIDY | 2019 |
|
RU2712175C1 |
| METHOD FOR DETERMINING FOETAL KARYOTYPE OF PREGNANT WOMAN BASED ON SEQUENCING HYBRID READINGS CONSISTING OF SHORT FRAGMENTS OF EXTRACELLULAR DNA | 2019 |
|
RU2717023C1 |
| NON-INVASIVE DETECTION OF GENETIC FOETAL ABNORMALITY | 2011 |
|
RU2589681C2 |
| METHOD OF DETERMINING THE SOURCE OF ANEUPLOID CELLS ON THE BLOOD OF A PREGNANT WOMAN | 2016 |
|
RU2674700C2 |
| METHODS AND SYSTEMS FOR DETERMINING WHETHER GENOME IS ABNORMAL | 2011 |
|
RU2599419C2 |
| METHOD AND APPARATUS FOR DETERMINING FRACTION OF EXTRACELLULAR NUCLEIC ACIDS IN BIOLOGICAL SAMPLE AND USE THEREOF | 2015 |
|
RU2699728C2 |
